Jin Mao Partners 金 茂 凯 德 律 师 事 务 所 13F,HongKong New World Tower, No.300 Huaihai Zhong Rd, Shanghai, 200021,P.R.C. 中国上海淮海中路 300 号香港新世界大厦 13 层邮编：200021 Tel/电话:(8621)63872000 Fax/传真:(8621)63353272 上海金茂凯德律师事务所 关于上海悦心健康集团股份有限公司 2025 年第一次临时股东大会的法律意见书 致：上海悦心健康集团股份有限公司 上海悦心健康集团股份有限公司（以下简称"公司"）2025 年第一次临时股 东大会（以下简称"本次股东大会"）于 2025 年 6 月 11 日下午在上海市闵行区浦 江镇三鲁公路 2121 号公司会议室召开。上海金茂凯德律师事务所（以下简称"本 所"）经公司聘请委派游广律师、张博文律师（以下简称"本所律师"或"经办律 师"）出席会议，并根据《中华人民共和国公司法》（以下简称"《公司法》"） 《中华人民共和国证券法》（以下简称"《证券法》"）《上市公司股东会规则》 （以下简称"《股东会规则》"）《深 ...

证券代码：002162 证券简称：悦心健康 公告编号：2025-047 上海悦心健康集团股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会没有否决提案的情形； 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 （2）网络投票时间： ①通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 6 月 11 日 9:15-9:25、9:30-11:30、13:00-15:00； ②通过深圳证券交易所互联网投票系统进行网络投票的具体时间为 2025 年 6 月 11 日 9:15—15:00 时的任意时间。 2、会议召开地点：上海市闵行区浦江镇三鲁公路 2121 号召开。 本次股东大会由副董事长余璟先生主持召开。本次会议的召集、召开与表决程序 符合有关法律、行政法规、部门规章、规范性文件和公司《章程》的相关规定。 （二）会议出席情况 1、股东总体出席情况： 通过现场投票和网络投票的股东及股东授权委托代表583名，代表股份 482,6 ...

Core Viewpoint - The article highlights the rapid development and potential of the elderly care robotics market in China, driven by technological advancements and supportive government policies, with a projected market size of 7.21 trillion yuan by 2025 and a compound annual growth rate exceeding 30% for elderly care robots [2][8]. Policy Support and Market Growth - The Chinese government has initiated a three-year pilot program for smart elderly care robots, requiring validation in at least 200 households and deployment in over 20 communities or institutions [3][6]. - The "Smart Health and Elderly Care Industry Development Action Plan (2021-2025)" emphasizes elderly care robots as a core direction for smart elderly care devices [6][8]. - By 2024, the elderly population in China is expected to reach 297 million, with over 44 million classified as disabled or semi-disabled, indicating a significant market opportunity [8][9]. Industry Challenges - The elderly care robotics industry faces challenges such as a lack of high-quality data for accurate demand forecasting and reliance on imported core components, leading to high R&D costs [10][11]. - There is a significant gap in consumer awareness regarding the functionalities of elderly care robots, with many potential users unaware of their capabilities [12][14]. Market Segmentation - Elderly care robots are categorized into three main types: nursing robots for daily care, rehabilitation robots for mobility assistance, and companion robots for emotional support [11]. - The current market shows a preference for lower-cost devices, with high-end products priced between 500,000 to 1 million yuan, which conflicts with the spending habits of elderly consumers [14]. Key Companies in the Industry - **Ousheng Electric**: Focuses on comprehensive solutions for nursing robots, with a significant increase in orders and revenue contribution from this segment [16][17]. - **Yuexin Health**: Aims to integrate health monitoring and smart elderly care systems, operating nearly 3,000 beds in the Yangtze River Delta region [18]. - **MediTech**: Specializes in intelligent care robots, collaborating with major tech companies to enhance the functionality and integration of their products in healthcare settings [20][21]. - **Zhenjiang Co.**: Engages in the development of exoskeleton robots for rehabilitation, with plans for mass production and market expansion [22]. - **Rongtai Health**: Innovates in health management through AI and machine learning, focusing on personalized health solutions for the elderly [23][24].

Core Points - The company has completed the cancellation of stock options that were not exercised during the first exercise period of the 2023 stock option incentive plan, totaling 305.2127 thousand options [1][2][3] Group 1: Reasons for Cancellation - 5.1127 thousand options were canceled due to the expiration of the first exercise period without being exercised [2] - 42.85 thousand options were canceled because 6 incentive recipients left the company, losing their eligibility [2] - 257.25 thousand options were canceled as the company did not meet the performance assessment criteria for the 2024 fiscal year, which required a revenue trigger of 1.4 billion [2] Group 2: Completion Status - The cancellation of the stock options was confirmed by the China Securities Depository and Clearing Corporation Limited on June 9, 2025 [3] Group 3: Impact on the Company - The cancellation of the stock options complies with relevant laws and regulations and will not affect the company's capital structure or financial performance significantly [3]

上海悦心健康集团股份有限公司 关于2023年股票期权激励计划部分股票期权注销完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，不存在虚假 记载、误导性陈述或者重大遗漏。 特别提示： 证券代码：002162 证券简称：悦心健康 公告编号：2025-046 根据《公司 2023 年股票期权激励计划》的相关规定，有 6 位激励对象因个人原 因离职（其中，2 位是首次授予激励对象，3 位是预留授予激励对象，1 位同时是首 次与预留授予激励对象），不再具备激励对象资格，其已获授但尚未行权的股票期 权不得行权，共计 42.85 万份（其中,首次授予部分份额为 17.85 万份；预留授予部 分份额为 25 万份），将由公司注销。 1、本次注销2023年股票期权激励计划股票期权数量共计305.2127万股。 2、经中国证券登记结算有限责任公司深圳分公司审核确认，公司本次2023年股票期 权激励计划部分股票期权注销事宜已于2025年6月9日办理完成。 上海悦心健康集团股份有限公司（以下简称"公司"）于2025年5月26日召开了 第八届董事会第十五次会议、第八届监事会第十二次会议，审议通过了《关于2023 年 ...

暗盘资金一眼洞悉庄家意图>> 牙科医疗板块盘初拉升，皓宸医疗（002622）封板涨停，爱迪特（301580）涨超5%，康惠制药 （603139）、悦心健康（002162）、正海生物（300653）、国瓷材料（300285）等均涨超2%。 ...

Group 1 - The A-share dental medical sector experienced a significant rise at the beginning of trading, with Haocen Medical hitting the daily limit and closing up [1] - Aidi Te rose over 5%, while Kanghui Pharmaceutical, Yueshin Health, Zhenghai Biological, and Guoci Materials all increased by more than 2.5% [1]

Group 1: Industry Overview - In the first four months of 2023, the home decoration consumer goods sector saw the addition of 1.332 million new products, marking a year-on-year increase of 560.8%, with smart home products experiencing a staggering growth of 1985.5% [1] - The Chinese furniture industry reported a 20.2% year-on-year increase in retail sales due to the "old-for-new" policy, while exports faced a 7.9% decline [2] - The 29th China International Kitchen and Bathroom Facilities Exhibition showcased over 1,300 leading brands, focusing on integrated, smart, and green technologies [3] Group 2: Company Developments - Red Star Macalline plans to issue asset-backed securities worth up to 1.768 billion yuan to optimize its financing structure [4] - A flagship store of Yiqizhuangxiu, covering 20,000 square meters, has opened, emphasizing a one-stop home decoration service [5] - Zhigang Home launched a "Whole Health Home" standard system, aiming to address diverse family health needs [6] Group 3: Financial Performance - Yueshen Health reported a loss of 452 million yuan in undistributed profits and plans to use 214 million yuan from its surplus to cover losses [7] - The HuRun Global Ceramics List revealed that China has the highest number of listed ceramic companies, with seven firms making the top rankings [8] Group 4: New Projects and Initiatives - The Nankang Furniture Brand Operation Center project has commenced with a total investment of 2 billion yuan [9] - Golden Home opened its first overseas shared store in Malaysia, marking a significant step in its international expansion [10] - Mengbaihe launched its first flagship store for the VALUE series, targeting cost-effective solutions for families in lower-tier cities [11] Group 5: Market Trends - Oppein Home reported a 47.4% increase in contract liabilities due to national subsidies, while revenue decreased by 4.8% [12] - Wanhua Ecological New Home Decoration Group opened a new facility in Chengdu, focusing on green industrialized customization [13] - Serta Smart Bed partnered with Tmall Genie to offer smart sleep solutions, indicating a shift towards integrated smart home experiences [14] - JD.com launched its self-operated home decoration brands, enhancing its market presence through direct connections with manufacturers [15]

证券代码：002162 证券简称：悦心健康 公告编号：2025-045 上海悦心健康集团股份有限公司 关于回购股份注销完成暨股份变动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，不存在虚假 记载、误导性陈述或者重大遗漏。 特别提示： 1、本次注销的回购股份数量为2,405,700股，占注销前公司总股本的0.26%，实际回 购注销金额为人民币9,998,228元。本次注销完成后，公司总股本由922,106,665股 减少至919,700,965股。 2、经中国证券登记结算有限责任公司深圳分公司审核确认，公司本次回购股份注销 事宜已于2025年5月28日办理完成。 一、本次回购公司股份方案的审批及实施情况 上海悦心健康集团股份有限公司（以下简称"公司"）分别于 2025 年 2 月 26 日、2025 年 3 月 25 日召开了第八届董事会第十三次会议、2024 年度股东大会，审 议通过了《关于公司回购股份方案的议案》，同意公司使用自有资金或自筹资金以 集中竞价交易的方式回购公司部分已发行的人民币普通股（A 股）股票，回购股份将 全部用于注销并减少公司注册资本。本次回购总金额不低于人民币 60 ...

Group 1 - The company held the 12th meeting of the 8th Supervisory Board on May 26, 2025, to discuss various resolutions [2][3] - The Supervisory Board approved the cancellation of unexercised stock options from the first exercise period of the 2023 stock option incentive plan, which will not materially affect the company's financial status or operational results [3][4] - The company will hold its first extraordinary general meeting of shareholders on June 11, 2025, to discuss various proposals, including changes to registered capital and amendments to the Articles of Association [7][8][12] Group 2 - The company plans to use surplus reserves to cover accumulated losses, amounting to approximately 213.91 million yuan, which will reduce the accumulated losses to about 238.26 million yuan after the adjustment [24][25][26] - The company’s wholly-owned subsidiary will inject 600 million yuan into its wholly-owned subsidiary, enhancing its financial structure and reducing the debt ratio [28][29][33] Group 3 - The company approved the cancellation of stock options due to unfulfilled performance conditions, totaling approximately 300.10 million options, which is about 0.33% of the company's total share capital [39][42] - The company’s stock option incentive plan has undergone necessary approvals and will not adversely affect the company's financial status or shareholder interests [44][46] Group 4 - The company will change its registered capital from 922,106,665 yuan to 919,700,965 yuan following the completion of a share buyback program [62] - The company has decided to abolish the Supervisory Board, transferring its responsibilities to the Audit Committee of the Board of Directors [63]